Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01885052 · ClinicalTrials.gov registry record · Phase 2
Evaluation of National Cancer Institute Young Adult Stop-Smoking Program
A Phase 2 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 2
- Development phase
- 4,432
- Enrollment target
NCT01885052: Completed Phase 2 study, sponsored by National Cancer Institute (NCI).
NCT01885052 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 4,432 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01885052, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 4,432 participants
- Enrollment target
Study Summary
Background: \- Researchers want to see how well the QuitTXT text-message program helps smokers ages 18 29 stop smoking. This is part of a larger online stop-smoking program by the National Cancer Institute. The QuitTXT program is a 2-week countdown to the smoker s quit date with 6 weeks of follow-up messages. Program participants will receive texts on their cell phones, including tips, information, and motivational messages, and then fill out surveys. Objectives: \- To study how well the QuitTXT program helps smokers ages 18 29 stop smoking. Eligibility: \- Adults ages 18 29 who have smoked on at least 5 of the past 30 days and who want to stop smoking in the next 30 days. Design: * Participants will receive a certain number of text messages during the 8-week study. They will receive between 0 to 5 messages per day (or up to a total of 130 messages). * Participants will first fill out a survey about their smoking and quitting experiences. Then they will choose a date to quit smoking (a quit date ) between 2 and 3 weeks after this survey. * Participants will take four other surveys online, one during the program and three more after they ve completed the program. Each survey will take about 10 20 minutes and asks about their smoking habits and views on smoking and quitting. Each survey will be sent by email, with reminders sent by email or telephone. * Participants will receive an iTunes or Amazon gift card for completing each survey honestly.
Interventions
- BEHAVIORAL QuitTXT Study
- BEHAVIORAL Low Contact
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,432 participants |
| Start Date | 2013-06-12 |
| Est. Completion | 2015-05-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01885052
The ClinicalTrials.gov registry entry for NCT01885052 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 4,432 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which QuitTXT Study is the first listed.
NCT01885052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01885052 about?
NCT01885052 is a clinical study titled "Evaluation of National Cancer Institute Young Adult Stop-Smoking Program". Background: \- Researchers want to see how well the QuitTXT text-message program helps smokers ages 18 29 stop smoking. This is part of a larger online stop-smoking program by the National Cancer Institute. The QuitTXT program is a 2-week countdown to the smoker s quit date with 6 weeks of follow-u...
What is the current status of trial NCT01885052?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 4,432 participants. The study started on 2013-06-12. Estimated completion is 2015-05-28.
What interventions are being tested in trial NCT01885052?
The interventions under investigation include: QuitTXT Study (BEHAVIORAL), Low Contact (BEHAVIORAL).
Who is sponsoring clinical trial NCT01885052?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.